pharmaceutical investing Foamix Reports First Quarter 2018 Financial Results and Provides Corporate Update
pharmaceutical investing VBL Therapeutics Announces Top-Line Results from Pivotal Phase 3 GLOBE Study
pharmaceutical investing Melinta Therapeutics Publishes Complete Results from Phase 3 TANGO I Study of VABOMERE
pharmaceutical investing Intercept Announces Phase 3 REVERSE Trial Evaluating OCA for the Treatment of NASH Patients
Oreterra Receives Conditional Approval to Sell Option to Buy Down Newmont Lake Royalty to Enduro Metals
Harvest Gold Announces Non-Brokered Private Placement To Fund 2026 Drill Program On Its Flagship Mosseau Property
